65 /100
HIGH RISK
Score updated May 30, 2026

APCX — AppTech Payments Corp. Dilution Risk Tracker

Track APCX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track APCX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
95
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split 70%
• 50-day avg $0.45 below $1 exchange minimum
• Only 3 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 2.7 months cash remaining
📉 Score Deterioration 50%
• Score rose 46 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔔 Track APCX — Get forecast alerts →

💹 Market Data

Market Cap$14.91M
Shares Outstanding42.00M
Float34.59M
Cash$110.0K
Debt$3.93M
Short InterestN/A

🏛 Institutional Holdings

0.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track APCX for full holder detail →

📉 Short Interest

Short Interest83
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Sep 30, 2025
8-K 8K EVENT Apr 10, 2026
4 INSIDER TRANSACTION Mar 05, 2026
4 INSIDER TRANSACTION Mar 05, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track APCX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking APCX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: BATL BRN CDIO CDT CNTMD
🔬 More Research for APCX
📊 APCX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 APCX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.